Preliminary Phase 1 Study Results Show Strong Anti-Tumor Activity and Favorable Safety Profile for First-in-Class Small ...
Early PrimeC treatment slowed functional decline and reduced the risk of death or ALS complications for ALS patients in a ...
Research identifies ribosome biogenesis factor MYBBP1A as a driver of acute myeloid leukaemia growth, highlighting a ...
Acurastem received a grant to develop ALS therapies targeting SYF2, a regulator of TDP-43, in collaboration with academic research teams.
A research team from The Hong Kong University of Science and Technology (HKUST) has made a breakthrough discovery in understanding the molecular ...
A metabolic enzyme studied for over seven decades has a hidden second function—it can unwind RNA and promote cell cycle progression, an additional function beyond its role in energy production, ...
By tagging neurons with molecular "barcodes," researchers have mapped connections among thousands of neurons in the mouse ...
Dyne Therapeutics' Z-basivarsen led to gains in motor function and cognition for myotonic dystrophy type 1, and is entering a ...
A simulated cell in the early stages of division. Left half shows membrane (green cubes), and ribosomes (yellow/purple) interwoven through in the cell’s chromosome (red). Right side shows all the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results